chrX-8170151-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_016378.3(VCX2):āc.301C>Gā(p.His101Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000018 ( 0 hom., 0 hem., cov: 8)
Exomes š: 0.000019 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
VCX2
NM_016378.3 missense
NM_016378.3 missense
Scores
2
15
Clinical Significance
Conservation
PhyloP100: 0.905
Genes affected
VCX2 (HGNC:18158): (variable charge X-linked 2) This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes that are expressed exclusively in male germ cells. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This gene contains two copies of a 30 nt tandem repeat. Deletion of a nearby member of this family was implicated in cognitive disability. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.050736338).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCX2 | NM_016378.3 | c.301C>G | p.His101Asp | missense_variant | 3/3 | ENST00000317103.5 | NP_057462.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCX2 | ENST00000317103.5 | c.301C>G | p.His101Asp | missense_variant | 3/3 | 1 | NM_016378.3 | ENSP00000321309.4 | ||
ENSG00000285679 | ENST00000649338.1 | n.263-58184G>C | intron_variant | |||||||
ENSG00000285679 | ENST00000659022.1 | n.972-58184G>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 1AN: 56162Hom.: 0 Cov.: 8 AF XY: 0.00 AC XY: 0AN XY: 6516
GnomAD3 genomes
AF:
AC:
1
AN:
56162
Hom.:
Cov.:
8
AF XY:
AC XY:
0
AN XY:
6516
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000190 AC: 20AN: 1054941Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 337033
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
20
AN:
1054941
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
337033
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000178 AC: 1AN: 56162Hom.: 0 Cov.: 8 AF XY: 0.00 AC XY: 0AN XY: 6516
GnomAD4 genome
AF:
AC:
1
AN:
56162
Hom.:
Cov.:
8
AF XY:
AC XY:
0
AN XY:
6516
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
26
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.301C>G (p.H101D) alteration is located in exon 3 (coding exon 2) of the VCX2 gene. This alteration results from a C to G substitution at nucleotide position 301, causing the histidine (H) at amino acid position 101 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Gain of relative solvent accessibility (P = 0.0098);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at